Urology - European Medical Journal

Continue

Urology

Filter
13 Dec 2023

How to Translate Science into Patient Care: Long Term Outcomes in Clinical Trials

Watch our latest webinar on-demand now, exploring the ways in which clinical decision making is affected by long term outcomes in…
29 Nov 2023

Does PSMA Change the Role of Surgery in Prostate Cancer?

This webinar explores prostate-specific membrane antigen (PSMA) positron emission tomography/CT. This technique is becoming increasingly…
27 Nov 2023

Translating Science into Patient Care: How are we treating muscle invasive bladder cancer patients today?

Watch our latest webinar on muscle invasive bladder cancer (MIBC), which outlines the journey of patients with MIBC, and key treatment…
21 Aug 2023

Live Webinar: Translating Science into Patient Care: How are we treating muscle invasive bladder cancer patients today? October 10th 3:00 PM - 4:30 PM BST

This webinar will explore current treatment options for patients with muscle-invasive urothelial carcinoma.
27 Mar 2023

EAU23 Highlights: Best treatments for localised disease

Dr Alberto Bossi. During EAU23 in Milan, Dr Alberto Bossi discusses the most recent advances in treatments for localised disease.
EMJ
27 Mar 2023

EAU23 Highlights: Advanced hormone sensitive prostate cancer

Prof. Bernd Schmitz-Dräger. On the third day of EAU23 in Milan, Professor Bernd Schmitz-Dräger presents highlights from the congress in advanced hormone sensitive prostate cancer treatment.
27 Mar 2023

EAU23 Highlights: Screening, early detection and advanced prostate cancer

Professor Peter Hammerer. On the final day of EAU23 in Milan, Professor Peter Hammerer provides updates from the congress on screening, early detection and advanced prostate cancer.
6 Dec 2022

Navigating the Integration of Immuno-Oncology Into the Perioperative Muscle-Invasive Urothelial Carcinoma Treatment Landscape

Chaired by Prof. Andrea Necchi, this symposium presented by Prof. Rouprêt and Prof. Retz explores the treatment landscape for muscle-invasive urothelial carcinoma, as well as their perspectives on future treatment landscape.